Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2023-04-04 Regulatory Filings
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the publication of a peer-reviewed scientific article related to the company's analgesic program. It discusses research and development progress, publication details, and forward-looking statements. There are no financial statements, regulatory filings, voting results, or management changes. The content is primarily an announcement of a scientific publication and company research progress, not a formal financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general Regulatory Filing (RNS) because it is a regulatory announcement that does not fit other specific categories.
2023-04-04 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the initiation of a clinical development program and the appointment of a disclosure committee by PreveCeutical Medical Inc. It contains forward-looking statements about the company's plans and ongoing research activities. There are no financial statements, detailed financial data, or regulatory filings such as annual or quarterly reports. The content is primarily an update on clinical and corporate developments rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an announcement of company activities and management committee changes, but not specifically a management or board change announcement filing. Given the nature of the content as a corporate update and announcement, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2023-03-20 English
News release - English.pdf
Regulatory Filings
2023-03-06 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new member to the company's board of directors. It details the background and qualifications of the appointee and includes comments from the CEO and the new board member. There are no financial statements, earnings data, or detailed management analysis. The content focuses solely on management changes at the board level. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and contains no indication that it is a report or a regulatory filing of another type.
2023-02-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the appointment of a clinical research organization (ICON) to conduct clinical development for PreveCeutical Medical Inc.'s analgesic program. It discusses plans for clinical trials, regulatory interactions, and forward-looking statements about the company's development strategy. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The document is an announcement of a business development related to clinical trials and partnerships, not a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general corporate announcement about clinical development progress and partnerships, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement or corporate update that does not fit other specific categories.
2023-02-07 English
News release - English.pdf
Regulatory Filings
2023-01-25 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.